NYSE: $MRK A Breakthrough in Renal Cell Carcinoma Treatment The U.S. Food and Drug Administration (FDA) has officially approved a significant new treatment option for patients battling advanced kidney cancer. The combination of Welireg (belzutifan) and Lenvima (lenvatinib) is now indicated for adult patients with advanced renal cell carcinoma (RCC) who have previously received treatment…